AUB
CRSP icon

Atlantic Union Bankshares’s CRISPR Therapeutics CRSP Stock Holding History

Atlantic Union Bankshares’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
3,343
+525
+19% +$27.7K ﹤0.01% 645
2026
Q1 		$134K Buy
2,818
+166
+6% +$8.76K ﹤0.01% 673
2025
Q4 		$139K Sell
2,652
-233
-8% -$14K ﹤0.01% 663
2025
Q3 		$187K Buy
2,885
+2,203
+323% +$126K ﹤0.01% 613
2025
Q2 		$33.2K Buy
+682
New +$26.4K ﹤0.01% 734

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Atlantic Union Bankshares's CRSP Position: Q2 2026 in Review

Atlantic Union Bankshares increased its CRISPR Therapeutics (CRSP) stake by 19% in Q2 2026, buying an estimated $27.7K and bringing the position to 3,343 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Atlantic Union Bankshares first reported a position in CRSP in Q2 2025 and has held it in 5 quarters since. The position peaked at $187K in Q3 2025. 524 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Atlantic Union Bankshares held 3,343 shares of CRISPR Therapeutics worth $182K as of Q2 2026.
  • Atlantic Union Bankshares bought 525 CRISPR Therapeutics shares in Q2 2026, an estimated $27.7K.
  • CRISPR Therapeutics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #645 holding.
  • Atlantic Union Bankshares first reported a position in CRISPR Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Atlantic Union Bankshares's CRISPR Therapeutics position peaked at $187K in Q3 2025.
  • 524 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.